Management of homozygous familial hypercholesterolaemia--unmet needs, updated recommendations, and clinical experience with the MTP inhibitor, lomitapide : concluding comments / A.L. Catapano. - In: ATHEROSCLEROSIS SUPPLEMENTS. - ISSN 1567-5688. - 15:2(2014), pp. 52-52. [10.1016/j.atherosclerosissup.2014.07.001]

Management of homozygous familial hypercholesterolaemia--unmet needs, updated recommendations, and clinical experience with the MTP inhibitor, lomitapide : concluding comments

A.L. Catapano
Primo
2014

Apheresis; Drug-drug interactions; Homozygous familial hypercholesterolaemia; Lomitapide; Transaminase elevations; Cardiology and Cardiovascular Medicine; Internal Medicine
Settore BIO/14 - Farmacologia
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1567568814000154-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 120.02 kB
Formato Adobe PDF
120.02 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/251346
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact